BRKR Stock Analysis: Buy, Sell, or Hold?
BRKR - Bruker Corporation
$34.31
0.59 (1.75%)
▲
5d:
-1.58%
30d:
-14.46%
90d:
-28.54%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Distribution
BRKR is up 6.1% this week, but smart money is buying puts. Top strike: $45 2026-06-18 with 136 OI. Put ratio: 64% View Scanner →
Strength: 4.4/10
Get Alerted When BRKR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BRKR trading at deep discount. Market pricing in -9.9% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: BRKR trading at deep discount. Market pricing in -9.9% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$72.48
Based on 9.2% avg growth
INTRINSIC VALUE TODAY
$45.00
23.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BRKR is currently trading at $34.31, which is considered slightly low relative to its 30-day fair value range of $34.19 to $39.16. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.2) compared to its historical average (19.4). Remarkably, the market is currently pricing in an annual earnings decline of 9.9% over the next few years. This pessimistic expectation contrasts with the company's recent 8.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BRKR is in a downtrend. Immediate support is located at $33.08, while resistance sits at $37.00.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $47.86 (+39.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BRKR is in a downtrend. Immediate support is located at $33.08, while resistance sits at $37.00.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $47.86 (+39.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$34.19 -
$39.16
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.5% below Wall St target ($47.86)
Fair Price Analysis
30-Day Fair Range
$34.19 -
$39.16
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$33.08
Resistance Level
$37.00
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.19
Wall Street Target
$47.86
(+39.5%)
Revenue Growth (YoY)
-0.2%
Earnings Growth (YoY)
8.5%
Profit Margin
-0.2%
Valuation Discount vs History
-9.9% cheaper
PE vs Historical
14.2 vs 19.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.9%
(market-implied from PE analysis)
1-Year Target
$30.91
(-10%)
2-Year Target
$27.85
(-19%)
3-Year Target
$25.10
(-27%)
3-Yr Target (if PE normalizes)
(PE: 14→19)
$34.31
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 14.3%)
$80.68
(+135%)
Base:
(SPY PE: 14.2, Growth: 14.3%)
$51.22
(+49%)
Bear:
(PE: 12.1, Growth: 14.3%)
$43.53
(+27%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.2 to 19.4
Stabilization Target:
$46.91
(+36.7%)
PE Expansion Potential:
+36.7%
Share & Embed Analysis
Last updated: March 30, 2026 6:22 PM ET
Data refreshes hourly during market hours. Next update: 7:22 PM
Data refreshes hourly during market hours. Next update: 7:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRKR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Munch
SELL
2000 shares
2026-03-13
Mark Munch
SELL
2000 shares
2026-01-15
Mark Munch
SELL
7000 shares
2026-01-12
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 50 HOLD |
Advanced BRKR Option Strategies
Professional options setups generated by AI based on today's BRKR price and gamma walls.
